Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Cysteine engineered fibronectin type III domain binding molecules

Cysteine engineered fibronectin type III domain binding molecules

US Patent 11702475 · Granted Jul 18, 2023

Estimated economic value: $328,585,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

EPCAM binding fibronectin type III domains2025
Proteins comprising CD3 antigen binding domains and uses thereof2025
Macrocyclic chelators and methods of use thereof2025
Serum albumin-binding fibronectin type III domains and uses thereof2025
EGFR and C-met fibronectin type III domain binding molecules2025
EGFR and C-met fibronectin type III domain binding molecules2025
Fibronectin type III domain based scaffold compositions, methods and uses2025
Fibronectin type III domain based scaffold compositions, methods and uses2025
CD137 binding fibronectin type III domains2025
FN3 domain-siRNA conjugates and uses thereof2025
Radiolabeling of polypeptides2025
Site-specific conjugation of glycosylated monoclonal antibodies with transglutam2025